Insys Therapeutics: Today's Big Biotech Winner

Shares of Insys Therapeutics (NASDAQ: INSY  ) rose 20% today, after the company posted strong second-quarter results for its cancer-related pain medicine, Subsys. After operating at a loss last year, the 38% sales growth of the drug this year helped propel Insys to making a $24 million profit this year. Shares of the stock have doubled year to date and are up 600% over the past 12 months.

In this video, Motley Fool health-care analyst David Williamson looks at Insys. With sales of Subsys having now surpassed all estimates, this is one that he will definitely have on his radar going forward.

Looking for more portfolio-changing growth in 2014?
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.


Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 06, 2014, at 2:04 AM, crashchandler wrote:

    the reason INSYS is gaining market share is because of it's new business plan . Authorizing of medications are done thru the INSYS company. IF the patient cannot get authorization for the medication thru their insurance company the INSYS provides the medication for the patient free for life. The have a method for helping with the co- pay if the patient cannot afford it.

    This is a novel approach for the care of severe cancer pain uncontrolled by other medications.

    The founder John Kapoor lost his wife to cancer and she could not get adequate pain relief with the normal medications given by mouth because they were absorbed to slowly.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2863909, ~/Articles/ArticleHandler.aspx, 8/29/2014 4:30:44 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement